Stay updated with breaking news from Vivos Method. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Vivos Therapeutics said Wednesday the Food and Drug Administration has granted 510 clearance for its oral device treatment for severe obstructive sleep apnea in adults. The clearance is for its...
Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and Bioventus (NYSE:BVS – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership. Profitability This table compares Vivos Therapeutics and Bioventus’ […]
Vivos reported a decrease in Q3 revenue, juxtaposed against its efforts to expand internationally in the sleep treatment market.
Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and Silk Road Medical (NASDAQ:SILK – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Valuation and Earnings This table compares […]
Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Free Report) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 2,270,000 shares, an increase of 297.1% from the September 30th total of 571,600 shares. Based on an average daily trading volume, of 5,960,000 shares, the short-interest […]